Literature DB >> 10462060

Evidence for the presence of CB1 cannabinoid receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors.

R G Pertwee1.   

Abstract

The discovery of CB1 and CB2 receptors and of endogenous agonists for these receptors has sparked renewed interest in the therapeutic potential of cannabinoids. This has led to a need for strategies that will provide a better separation of wanted from unwanted effects, particularly for CB1 receptor agonists. Possible strategies are to target CB1 receptors present on neurones outside the central nervous system or novel types or subtypes of neuronal cannabinoid receptor. This paper reviews evidence for the presence of CB1 receptors on peripheral neurones and for the existence of neuronal non-CB1 cannabinoid receptors.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10462060     DOI: 10.1016/s0024-3205(99)00282-9

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  14 in total

Review 1.  The endocannabinoid system: role in energy regulation.

Authors:  Thomas F Gamage; Aron H Lichtman
Journal:  Pediatr Blood Cancer       Date:  2012-01       Impact factor: 3.167

Review 2.  [Cannabinoids--signal transduction and mode of action].

Authors:  R Rukwied; B Gauter; M Schley; C Konrad
Journal:  Schmerz       Date:  2005-11       Impact factor: 1.107

3.  [Topical cannabinoid agonists. An effective new possibility for treating chronic pruritus].

Authors:  S Ständer; H W Reinhardt; T A Luger
Journal:  Hautarzt       Date:  2006-09       Impact factor: 0.751

4.  HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor.

Authors:  L Hanus; A Breuer; S Tchilibon; S Shiloah; D Goldenberg; M Horowitz; R G Pertwee; R A Ross; R Mechoulam; E Fride
Journal:  Proc Natl Acad Sci U S A       Date:  1999-12-07       Impact factor: 11.205

5.  Differential effects of anandamide on acetylcholine release in the guinea-pig ileum mediated via vanilloid and non-CB1 cannabinoid receptors.

Authors:  C F Mang; D Erbelding; H Kilbinger
Journal:  Br J Pharmacol       Date:  2001-09       Impact factor: 8.739

Review 6.  Pharmacokinetics and pharmacodynamics of cannabinoids.

Authors:  Franjo Grotenhermen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  In vivo effects of CB2 receptor-selective cannabinoids on the vasculature of normal and arthritic rat knee joints.

Authors:  J J McDougall; V Yu; J Thomson
Journal:  Br J Pharmacol       Date:  2007-11-05       Impact factor: 8.739

Review 8.  Pharmacology of vagal afferent influences on disordered breathing during sleep.

Authors:  David W Carley; Miodrag Radulovacki
Journal:  Respir Physiol Neurobiol       Date:  2008-12-10       Impact factor: 1.931

9.  N-acylethanolamine signaling in tobacco is mediated by a membrane-associated, high-affinity binding protein.

Authors:  Swati Tripathy; Kathryn Kleppinger-Sparace; Richard A Dixon; Kent D Chapman
Journal:  Plant Physiol       Date:  2003-04       Impact factor: 8.340

10.  Metabolism of Anandamide by Human Cytochrome P450 2J2 in the Reconstituted System and Human Intestinal Microsomes.

Authors:  Vyvyca J Walker; Alisha P Griffin; Dagan K Hammar; Paul F Hollenberg
Journal:  J Pharmacol Exp Ther       Date:  2016-03-21       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.